Defining and investigating difficult asthma: Developing quality indicators

Respiratory Medicine

Volumn 100, Issue 7, 2006, Pages 1254-1261

  Prys Picard, C O ^a   Campbell, S M ^b   Ayres, J G ^c   Miles, J F ^d   Niven, R M ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Asthma; Consensus techniques; Difficult; RAND appropriateness method

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID DERIVATIVE; LONG ACTING DRUG;

ARTICLE; ASTHMA; CLINICAL ASSESSMENT; CLINICAL INDICATOR; CONTROLLED STUDY; DRUG MEGADOSE; HEALTH CARE DELIVERY; HEALTH CARE NEED; HOSPITAL ADMISSION; HOSPITAL PERSONNEL; HUMAN; MEDICAL SOCIETY; MEDICAL SPECIALIST; METHODOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RATING SCALE; RESOURCE MANAGEMENT; SYMPTOMATOLOGY; UNITED KINGDOM;

ANTI-ASTHMATIC AGENTS; ASTHMA; CONSENSUS; GREAT BRITAIN; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; QUALITY INDICATORS, HEALTH CARE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; TREATMENT FAILURE;

EID: 33744523122     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2005.10.013     Document Type: Article

References (26)

1. Dolan C.M., Fraher K.E., Bleecker E.R., et al. Design and baseline characteristics of the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 92 1 (2004) 32-39
2. American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 162 6 (2000) 2341-2351
3. Leung D.Y., and Szefler S.J. New insights into steroid resistant asthma. Pediatr Allergy Immunol 9 1 (1998) 3-12
4. Wamboldt F.S., Spahn J.D., Klinnert M.D., et al. Clinical outcomes of steroid-insensitive asthma. Ann Allergy Asthma Immunol 83 1 (1999) 55-60
5. Heaney L.G., Conway E., Kelly C., et al. Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol. Thorax 58 7 (2003) 561-566
6. Van Ganse E., Laforest L., Pietri G., et al. Persistent asthma: disease control, resource utilisation and direct costs. Eur Respir J 20 2 (2002) 260-267
7. Barnes P.J., and Woolcock A.J. Difficult asthma. Eur Respir J 12 5 (1998) 1209-1218
8. GINA. Gina workshop reports, global strategy for asthma management and prevention. Publication No. 02-3659, 2002.
9. British guideline on the management of asthma. Thorax 58 Suppl 1 (2003) 1-94
10. National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma update on selected topics-2002. J Allergy Clin Immunol 110 Suppl 5 (2002) S141-S219
11. Smith D.H., Malone D.C., Lawson K.A., Okamoto L.J., Battista C., and Saunders W.B. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 156 3 Pt 1 (1997) 787-793
12. Malone D.C., Lawson K.A., and Smith D.H. Asthma: an analysis of high-cost patients. Pharm Pract Manage Q 20 1 (2000) 12-20
13. Robinson D.S., Campbell D.A., Durham S.R., Pfeffer J., Barnes P.J., and Chung K.F. Systematic assessment of difficult-to-treat asthma. Eur Respir J 22 3 (2003) 478-483
14. Jones J., and Hunter D. Consensus methods for medical and health services research. BMJ 311 7001 (1995) 376-380
15. Naylor C.D. What is appropriate care?. N Engl J Med 338 26 (1998) 1918-1920
16. Black N., Murphy M., Lamping D., et al. Consensus development methods: a review of best practice in creating clinical guidelines. J Health Serv Res Policy 4 4 (1999) 236-248
17. Campbell S.M., Braspenning J., Hutchinson A., and Marshall M.N. Research methods used in developing and applying quality indicators in primary care. BMJ 326 7393 (2003) 816-819
18. Brook R.H., Chassin M.R., Fink A., Solomon D.H., Kosecoff J., and Park R.E. A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care 2 1 (1986) 53-63
19. Shekelle P.G., Kahan J.P., Bernstein S.J., Leape L.L., Kamberg C.J., and Park R.E. The reproducibility of a method to identify the overuse and underuse of medical procedures. N Engl J Med 338 26 (1998) 1888-1895
20. Chung K.F., Godard P., Adelroth E., et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. Eur Respir J 13 5 (1999) 1198-1208
21. Agency for Health Services Research. Using clinical practice guidelines to evaluate quality of care (1995), AHCPR, Rockville
22. Baker R. Principles of quality improvement. Part Two: Measuring quality. J Clin Governance 9 (2001) 153-156
23. Shekelle P.G., Kahan J.P., Park R.E., Bernstein S.J., Leape L.L., Kamberg B.A., et al. Assessing appropriateness by expert panels: how reliable?. J Gen Intern Med 10 (1996) 81
24. Chetta A., Gerra G., Foresi A., Zaimovic A., Del Donno M., Chittolini B., et al. Personality profiles and breathlessness perception in outpatients with different gradings of asthma. Am J Respir Crit Care Med 157 1 (1998) 116-122
25. Veen J.C., Smits H.H., Ravensberg A.J., Hiemstra P.S., Sterk P.J., and Bel E.H. Impaired perception of dyspnea in patients with severe asthma. Relation to sputum eosinophils. Am J Respir Crit Care Med 158 4 (1998) 1134-1141
26. Marshall M.N., Shekelle P.G., McGlynn E.A., Campbell S., Brook R.H., and Roland M.O. Can health care quality indicators be transferred between countries?. Qual Saf Health Care 12 1 (2003) 8-12